Sort
78,016 grants matching “breast cancer”
MBAT A novel psychosocial cancer intervention
$443,377Daniel A Monti · Thomas Jefferson University · R01 · FY2007 · CA
Transcription Factor Mutants of Yeast
$443,333Karen M Arndt · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · GM
Identifying a proteomic signature for breast cancer detection in breast milk and serum
$443,330Costel C. Darie · Clarkson University · R15 · FY2022 · CA
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance
$443,314Amy Brock · University Of Texas At Austin · U01 · FY2020 · CA
Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy
$443,281Anand T.n. Kumar · Massachusetts General Hospital · R01 · FY2022 · CA
Project 2 - Molecular Imaging of ectopic calcification
$443,274Richard Blair Thompson · Medical College Of Wisconsin · P01 · FY2024 · AG
Microfluidic sorting of lung cancer cells from leukapheresis product as an alternative to metastatic tumor biopsy
$443,269Mehmet Toner · Massachusetts General Hospital · R01 · FY2022 · CA
Microfluidic sorting of lung cancer cells from leukapheresis product as an alternative to metastatic tumor biopsy
$443,269Mehmet Toner · Massachusetts General Hospital · R01 · FY2023 · CA
Transforming Growth Factor-Beta Signal Transduction
$443,262Joan Massague · Sloan-Kettering Inst Can Research · R37 · FY2008 · CA
Transforming Growth Factor-Beta Signal Transduction
$443,262Joan Massague · Sloan-Kettering Inst Can Research · R37 · FY2007 · CA
Transforming Growth Factor-Beta Signal Transduction
$443,262Joan Massague · Sloan-Kettering Inst Can Research · R37 · FY2009 · CA
Nitric Oxide as a Modifier of Oxidative Stress
$443,259David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
A high- multiplexed phosphotyrosine profiling assay
$443,242University Of Connecticut Sch Of Med/Dnt · R33 · FY2005 · CA
A Pathway of Tumor Suppression
$443,233Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Engineered biomimetic collective cancer invasion models for screening chemotherapeutic agents
$443,191Eun Hyun Ahn · Johns Hopkins University · R01 · FY2024 · CA
The Role of Schwann Cells in the Progression of Melanoma
$443,178Yuri Bunimovich · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Protein Biomarkers of Cancer Risk in Older Persons
$443,168Christopher I Li · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
Overcoming Drug Resistance in HER2-positive Breast Cancer
$443,163Yuesheng Zhang · Virginia Commonwealth University · R01 · FY2024 · CA
Blockade of cMYC oncogenic function by pregnancy-induced alterations and remodeling of the mammary gland
$443,162Camila Dos Santos · Cold Spring Harbor Laboratory · R01 · FY2024 · CA
Identifying intercellular circuits driving cell phenotypes within a niche
$443,145Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Molecular Mechanisms underlying tRNA-fragment regulation of cancer
$443,132Sohail F. Tavazoie · Rockefeller University · R01 · FY2019 · CA
Impact of pathogenic missense mutations on the ARID domain of ARID1a
$443,128Hugo Sanabria · Clemson University · R15 · FY2023 · CA
Activation of the beta-3 integrins: Role of the kindlins
$443,068Edward Franklin Plow · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · HL
PKC Alpha as a Marker for Logical Therapeutic Approaches to Breast Cancer
$443,067Debra Tonetti · University Of Illinois At Chicago · R01 · FY2009 · CA
Targeting through Selective Cell Labeling
$443,066Cecilia Maria Leal · University Of Illinois At Urbana-Champaign · R01 · FY2021 · EB